Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceutical Partners, Inc.    CPRX   US14888U1016

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
2.86(c) 2.88(c) 2.875(c) 2.85(c) 2.89(c) Last
336 803 243 576 369 385 223 041 169 887 Volume
-0.35% +0.70% -0.17% -0.87% +1.40% Change
More quotes
Company
Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and... 
More about the company
Surperformance© ratings of Catalyst Pharmaceutical Pa
Trading Rating : Investor Rating : -
More Ratings
Chart CATALYST PHARMACEUTICAL PA
Duration : Period :
Catalyst Pharmaceutical Pa Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -14,6 M
Net income 2014 -16,1 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -13,8 M
Net income 2015 -16,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 200 M
More Financials
Latest news on CATALYST PHARMACEUTICAL PA
4d ago Catalyst Pharmaceuticals Announces the Passing of Hubert E. Huckel, Co-Founde..
12/01 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Present at the Piper Jaffr..
11/26 CATALYST PHARMACEUTICAL PARTNERS : Patent Application Titled "Method of Treating..
11/24 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Notice of Allowance..
11/14 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Third Quarter 2014 ..
11/04 Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities ..
10/28 Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient..
10/27 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Present Firdapse Phase 3 T..
More news
Sector news
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
1d ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF